» Articles » PMID: 37126206

Immunohistochemistry of Leukemia Inhibitory Factor and Integrin αVβ3 in Mouse Endometrium Following Kisspeptin-54 Ovulation Trigger

Overview
Journal Reprod Sci
Publisher Springer
Date 2023 May 1
PMID 37126206
Authors
Affiliations
Soon will be listed here.
Abstract

Kisspeptin (KP) is a group of hypothalamic neuropeptides encoded by KISS-1 gene. KP-54, a 54-amino-acid peptide, helps regulate the hypothalamic-pituitary-ovarian axis and plays a potential role in implantation. C57BL/6 J female mice were superovulated via intraperitoneal injection of 5 International Units (IU) pregnant mare serum gonadotrophin (day 1). Forty-eight hours later, mice (5/group) were injected with phosphate-buffered saline (PBS) (group A), 5 IU human chorionic gonadotrophin (hCG) (group B), or 3 nmol KP-54 (group C). On day 7, mice were euthanized and uteri excised to create paraformaldehyde-fixed paraffin-embedded sections that were immunostained for the implantation markers: leukemia inhibitory factor (LIF) and integrin αVβ3 (ITG αVβ3). Slides were scored for intensity of staining in endometrial glandular epithelium (GE) and stromal cells (SCs) via histoscore (H-score). Data were analyzed using the Kruskal-Wallis test followed by the Mann-Whitney U test for pairwise comparisons. LIF expression was significantly higher in GE and SCs of mice triggered with KP-54 compared to placebo (P = .009 for both), but only higher than hCG trigger group in SCs (P = .009). Meanwhile, ITG αVβ3 expression was significantly higher in SCs of mice triggered with KP-54 compared to placebo (P = .028). In conclusion, using KP-54 as an ovulation trigger resulted in higher expression of the implantation markers LIF and ITG αVβ3 in mice endometrium compared to hCG or placebo. This suggests a potential role for KP-54 trigger in improving embryo implantation in clinical IVF. However, further studies are needed to correlate these results with clinical implantation rates and pregnancy outcomes.

Citing Articles

Global research trends in endometrial receptivity from 2000 to 2024: bibliometric analysis.

Liu Z, Zhang Z, Xie P Front Med (Lausanne). 2024; 11:1465893.

PMID: 39540052 PMC: 11558532. DOI: 10.3389/fmed.2024.1465893.

References
1.
Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T . Recurrent implantation failure: definition and management. Reprod Biomed Online. 2013; 28(1):14-38. DOI: 10.1016/j.rbmo.2013.08.011. View

2.
Bentin-Ley U, Horn T, Sjogren A, Sorensen S, Falck Larsen J, Hamberger L . Ultrastructure of human blastocyst-endometrial interactions in vitro. J Reprod Fertil. 2000; 120(2):337-50. DOI: 10.1530/jrf.0.1200337. View

3.
Coulam C, Chapman C, Rinehart J . What is a preclinical pregnancy loss?. J Assist Reprod Genet. 1998; 15(4):184-7. PMC: 3454932. DOI: 10.1023/a:1023044217810. View

4.
Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K . Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001; 411(6837):613-7. DOI: 10.1038/35079135. View

5.
Skorupskaite K, George J, Anderson R . The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014; 20(4):485-500. PMC: 4063702. DOI: 10.1093/humupd/dmu009. View